Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
66,342,236
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
20,703,857
-
Shares change
-
-1,169,359
-
Total reported value, excl. options
-
$364,387,973
-
Value change
-
-$15,203,525
-
Number of buys
-
33
-
Number of sells
-
-26
-
Price
-
$17.6
Significant Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q2 2021
63 filings reported holding BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share as of Q2 2021.
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,703,857 shares
of 66,342,236 outstanding shares and own 31.21% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (12,096,702 shares), Redmile Group, LLC (1,486,956 shares), MILLENNIUM MANAGEMENT LLC (1,456,034 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (778,567 shares), NUANCE INVESTMENTS, LLC (696,850 shares), PURA VIDA INVESTMENTS, LLC (544,545 shares), VANGUARD GROUP INC (517,493 shares), Tamarack Advisers, LP (475,000 shares), BlackRock Inc. (440,134 shares), and UBS ASSET MANAGEMENT AMERICAS INC (399,828 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.